Recruiting
Phase 2

Pembrolizumab Plus Olaparib in LA-HNSCC

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Code:

NCT05366166

Conditions

Squamous Cell Carcinoma of Head and Neck

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Olaparib

Cisplatin

IMRT (intensity modulated radiation therapy)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information